British Journal of Ophthalmology · 1952 · 23 citations · 34 references
MedicineOphthalmologyPharmacologyOcular DiseaseOcular PathologyRheumatologyAutoimmune Ocular DiseaseImmunopathology Of The EyeOcular InflammationRheumatoid ArthritisIndividual Therapeutic RangeRheumatoid Arthritis - Associated Ocular DiseaseTherapeutic Dose RangeTherapeutic Range Interpretation
Hench and his associates at the Mayo Clinic published their paper on the dramatic effects of cortisone and. ACTH on the subjective symptom- atology of rheumatoid arthritis. Shortly thereafter it was noted by several observers that these agents had a similar effect on the acute non-granulomatous iritis so often associated with rheumatoid arthritis. Although these sub- stances were then in scant supply and only a few cases of ocular disease could be treated, it soon became evident that they had a remarkable effect on various ocular inflammations. There was no information then available on the therapeutic range or limitations of these hormones, of the proper dosage or methods of administration, or of the mechanism through which they exerted their effect. A great deal was known, however, of their general physiological action, and certain definite contraindicptions to their use were recognized, although by no means all.
34
Philip S. Hench, Edward C. Kendall · Mayo Clinic Proceedings · 1949 · 1.2K citations · Full text
Biological Studies on Cortisone in Mice
David M. Spain, Norman Molomut, Alvin Haber · Science · 1950 · 137 citations
Local and Systemic Cortisone in Ocular Disease
Irving H. Leopold, J Purnell, Edmond J. Cannon et al. · American Journal of Ophthalmology · 1951 · 106 citations